Home » Company » History

History

of the elexxion AG

People need goals, dreams and visions. The dreamers and visionaries of today will own the world of tomorrow.

This quote is from an unknown author in the Middle Ages. With these dreams, Martin Klarenaar and Olaf Schäfer founded the company elexxion GmbH. The actual vision was to finally bring lasers to the market that allow dentists to offer their patients exceptionally pleasant treatments.

  • Low-pain to pain-free treatments, preferably without a syringe
  • Surgery without bleeding
  • Improved wound healing
  • Pain treatments
  • Selective hard tissue ablation
  • Effective yet non-invasive periodontal- and periimplantitis therapies
  • Good long-term results with as few recurrences as possible in periodontology and endodontics
  • From the very beginning, elexxion has relied on high-performance and high-peak-power pulsed technologies.
  • Today, we can say with pride that we belong to the world’s leading laser specialists.

Chronology:

  • 2002 Founding of elexxion GmbH
  • 2003 Set up of the company-own development- and production structures
  • 2004 Completion of the first successful diode laser elexxion claros for decontamination and
    soft tissue
  • 2005 Move to the “dental academy” with the first transparent production in Radolfzell
  • 2006 Entrepreneur of the year 2006 by Ernst & Young
  • 2006 Stock market launch, listed in Entry Standard of the Frankfurt Stock Exchange
  • 2007 Start of development of a PTT active ingredient “perio green”
  • 2008 M. Klarenaar leaves the company and P. Liljenqvist becomes new CEO
  • 2010 Development of the laser claros pico
  • 2013 Reappointment of M. Klarenaar to CEO
  • 2013 Development of the laser pico lite for activation of perio green
  • 2013 Market launch of perio green
  • 2015 Move to premises in Singen
  • 2016 Takeover of 55% of shares by Tian Ying Medical
  • 2017 Increase in share ownership by 30% to 85% in total by Tian Ying Medical
  • 2017 Xianlin Song becomes the Chairman of the Management Board
  • 2019 Capital increase of 899.000€